Who invested in Aegle Therapeutics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$2.7Mraised across 2 rounds since 2026, from 2 sources

$456KDebt$2.3MRound

Latest round: Round, $2.3MAug 2026
Step-upi: 5×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027

$456KDebt$2.3MRound

First round: Debt, $456K
Biggest round: $2.3M
Between rounds: 6 months

The rounds

Aug 2026
Round$2.3M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $2.3M sold, first sale Aug 2026
Mar 2026
Debt$456K2 new
- DeepWork Capital
- Ocean Azul Partners
Source recordedSEC filing: $456K sold, first sale Dec 2025

Founders and team

From Aegle Therapeutics's own website: 3 on the team.

Shelley A. HartmanCEO
Heidi KempinskiChief Operational Officer
Kathleen MurphyHead of Clinical Operations

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2026Round2026

DeepWork Capital

Ocean Azul Partners

Everyone who backed them

DeepWork CapitalVC firm1round

Ocean Azul PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Aegle Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.